{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:04:42Z","timestamp":1780491882327,"version":"3.54.1"},"reference-count":56,"publisher":"Informa UK Limited","issue":"22","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007136","name":"Karyopharm Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.2217\/fon-2021-0284","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:16:03Z","timestamp":1618485363000},"page":"2923-2939","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Health-Related Quality of Life and Pain with Selinexor in Patients with Advanced Dedifferentiated Liposarcoma"],"prefix":"10.1080","volume":"17","author":[{"given":"Mrinal","family":"Gounder","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College,\rNY\r10021, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albiruni R","family":"Abdul Razak","sequence":"additional","affiliation":[{"name":"Toronto Sarcoma Program,Princess Margaret Cancer Centre,\rToronto, ON, M5G 2C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M","family":"Gilligan","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyee","family":"Leong","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Ma","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Somaiah","sequence":"additional","affiliation":[{"name":"Department of Sarcoma Medical Oncology,The University of Texas MD Anderson Cancer Center,\rHouston, TX77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant P","family":"Chawla","sequence":"additional","affiliation":[{"name":"Sarcoma Oncology Center,\rSanta Monica, CA90403, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin-Broto","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine Research (IBIS)\/CSIC\/Universidad de Sevilla, Virgen del Rocio University Hospital, Calle Antonio Maura Montaner,\r41013, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-569X","authenticated-orcid":false,"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\r10060, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Schuetze","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology,University of Michigan,\rAnn Arbor, MI48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vincenzi","sequence":"additional","affiliation":[{"name":"Policlinico Universitario Campus, Bio-Medico,\rVia \u00c1lvaro del Portillo, 200, 00128, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,Dana-Farber Cancer Institute,\rBoston, MA02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Chmielowski","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology,Jonsson Comprehensive Cancer Center, UCLA,\rLos Angeles, CA90024, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L","family":"Jones","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research,\rLondon, SM2 5PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Shah","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Shacham","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kauffman","sequence":"additional","affiliation":[{"name":"Karyopharm Therapeutics,\rNewton, MA02459, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F","family":"Riedel","sequence":"additional","affiliation":[{"name":"Department of Medicine,Duke University Medical Center,\rDurham, NC27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Attia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, Mayo Clinic,\rJacksonville, FL32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32834796e6"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17082710"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0271"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12132-w"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24924"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1707"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70063-4"},{"key":"e_1_3_5_10_1","unstructured":"National Comprehensive Cancer Network (NCCN) Practice Guidelines in oncology: soft tissue sarcoma NCCN evidence blocks. (2020). https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/12\/article-p1604.xml?ArticleBodyColorStyles=pdf-5590"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.4734"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6605"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.5476"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0264"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5007"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-006-0001-4"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/740279"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S156279"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2018.05.008"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00903-4"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0412-4"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1457"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0408"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30120-4"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1706087"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.3949"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903455"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32292-3"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.6346"},{"key":"e_1_3_5_31_1","article-title":"SEAL: Phase III, randomized, double blind, cross-over, study of selinexor versus placebo in advanced unresectable dedifferentiated liposarcoma (DDLS)","author":"Gounder M","year":"2020","unstructured":"Gounder M , RazakAa, SomaiahNet al. SEAL: Phase III, randomized, double blind, cross-over, study of selinexor versus placebo in advanced unresectable dedifferentiated liposarcoma (DDLS). Connective Tissue Oncology Society (2020).","journal-title":"Connective Tissue Oncology Society"},{"key":"e_1_3_5_32_1","unstructured":"Karyopharm Therapeutics Inc. XPOVIO (selinexor) prescribing information. MA USA (2019)."},{"key":"e_1_3_5_33_1","volume-title":"EORTC QLQ\u2013C30 Scoring Manual.","author":"Fayers P","year":"1995","unstructured":"Fayers P , AaronsonNK, BjordalK, SullivanM. EORTC QLQ\u2013C30 Scoring Manual.European Organisation for research and treatment of cancer (1995). https:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1191\/1740774505cn119oa"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.139"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.03.016"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2372135"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01665.x"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.0922004"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70200-1"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy299.003"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019306"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2533-4"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/813483"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/325189"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5467057"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1255"},{"key":"e_1_3_5_49_1","unstructured":"World Health Organization . World Health Organization (WHO) guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. (2018). https:\/\/www.who.int\/publications\/i\/item\/9789241550390"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-385"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.05.023"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0301-9"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32462"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29426"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S106629"},{"issue":"4","key":"e_1_3_5_56_1","article-title":"COVID-19 and the impact on oral oncolytics: a specialty pharmacy perspective","volume":"2","author":"Claudia Castro","year":"2020","unstructured":"Claudia Castro , ManoogianA. COVID-19 and the impact on oral oncolytics: a specialty pharmacy perspective. Pharmacy Time2(4), (2020). https:\/\/www.pharmacytimes.com\/view\/covid-19-and-the-impact-on-oral-oncolytics-a-specialty-pharmacy-perspective","journal-title":"Pharmacy Time"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.3183"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.01.002"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:47:05Z","timestamp":1719125225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":56,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.2217\/fon-2021-0284"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0284","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}